Mobile app support for colorectal cancer patients
Official title: the Effect of the Interactive Nurse Support Program, Developed as a Mobile Application, on Patient Outcomes in Colorectal Cancer Patients Receiving Chemotherapy During the Covid-19 Process
Run by Ankara University · NCT05813028 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing a mobile app to see if it can help colorectal cancer patients feel better and manage their symptoms while they go through chemotherapy during the COVID-19 pandemic.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Ankara University Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Ankara, Çankaya) |
| Trial ID | NCT05813028 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 diagnosed with stage 0, 1, or 2 colorectal cancer who are first-time chemotherapy recipients and can effectively use an Android mobile phone.
✕Probably not a fit
Patients with metastatic colorectal cancer or those who have previously received chemotherapy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the impact of an interactive mobile application designed to support colorectal cancer patients undergoing chemotherapy during the COVID-19 pandemic. The application includes modules for COVID-19 information, symptom management, peer discussions, expert consultations, and shared patient experiences. It employs a randomized controlled, single-blind design to assess its effects on patient outcomes such as quality of life, social support, anxiety levels, and symptom management. The research is conducted at the Ankara City Hospital Medical Oncology Department Outpatient Clinics.
Why it matters
Potential benefit: If successful, this mobile application could significantly improve the quality of life and emotional well-being of colorectal cancer patients during their treatment.
How similar studies have gone: While similar studies focusing on mobile applications for patient support exist, this specific approach targeting colorectal cancer patients during the COVID-19 pandemic is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Volunteering to participate in research * Be over 18 years old * Being diagnosed with stage 0.1,2 colorectal cancer * Ability to understand and speak Turkish * ECOG performance score of 0.1 or 2 * Being literate * Having a mobile phone with an Android processor and being able to use it effectively * First time receiving chemotherapy Exclusion Criteria: * Presence of a diagnosed psychiatric illness * Having received previous chemotherapy * Diagnosis of metastatic colorectal cancer * ECOG performance score of 3 and 4 * Simultaneous radiation therapy with chemotherapy * Visual, auditory, mental or neurological disability * Taking part in another research that will affect the research results
Where it's running
-
Ankara Bilkent City Hospital
Ankara, Çankaya, Turkey Recruiting
Study contacts
- Study coordinator: burcu ağdemir, res. assis.
- Email: bagdemir@ankara.edu.tr
- Phone: +90 531 402 62 56
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Knife-assisted full-thickness resection for rectal lesions in a multicenter setting
A multicenter study tests knife-assisted full-thickness resection (kFTR) to remove rectal lesions in adults and see how well it works and how safe it is.
-
Personalized 3D Bioprinted Colorectal Cancer Microenvironment Model
This study tests patient-derived, 3D-bioprinted cancer models that include tumor, fibroblast, and immune cells to see if they can better predict how colorectal cancer will respond to treatment.
-
Integrated genomic and clinical database for cancer biomarker discovery
Researchers are building a combined genomic and clinical database at Samsung Medical Center to test biomarkers for cancer diagnosis, treatment choice, and predicting how well treatments work.
-
Prehabilitation with Resistance, Aerobic, or Both Before Colorectal Surgery
Four pre-surgery exercise options (resistance, aerobic, both, or none) will be tested to see which best reduces complications after colorectal cancer surgery.
-
Liver transplantation for colorectal cancer with liver metastases
This study follows adults with stage IV colorectal cancer whose disease is limited to the liver and who are getting a liver transplant as part of their cancer care to see how they fare over time.
-
LTZ-232: a first-in-human test in advanced colorectal and other solid tumors
A first-in-human study tests LTZ-232, a new therapy for adults with unresectable or metastatic colorectal cancer and other solid tumors that have not responded to standard treatments.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.